Document ID: chunk:federal_register_of_legislation:F2024C00213:front:0:p2
Version: federal_register_of_legislation:F2024C00213
Segment Type: other
Provision Reference: 
Character Range: 2887–5969

is made under subsection 196B(2) of the Veterans' Entitlements Act 1986.
     5               Application
This instrument applies to a claim to which section 120A of the VEA or section 338 of the Military Rehabilitation and Compensation Act 2004 applies.
     6               Definitions
The terms defined in the Schedule 1 - Dictionary have the meaning given when used in this instrument.
     7               Kind of injury, disease or death to which this Statement of Principles relates
(1)          This Statement of Principles is about myeloma and death from myeloma.
Meaning of myeloma
(2)          For the purposes of this Statement of Principles, myeloma:
(a)          means a malignant disease of plasma cells, in which a single line of plasma cells accumulates and produces a monoclonal immunoglobulin; and
(b)          includes:
(i)            extramedullary plasmacytoma;
(ii)         multiple myeloma;
(iii)       plasma cell leukaemia; and
(iv)        solitary plasmacytoma of bone.
(3)          While myeloma attracts ICD‑10‑AM code C90, in applying this Statement of Principles the meaning of myeloma is that given in subsection (2).
(4)          For subsection (3), a reference to an ICD-10-AM code is a reference to the code assigned to a particular kind of injury or disease in The International Statistical Classification of Diseases and Related Health Problems, Tenth Revision, Australian Modification (ICD-10-AM), Tenth Edition, effective date of 1 July 2017, copyrighted by the Independent Hospital Pricing Authority, ISBN 978-1-76007-296-4.
Death from myeloma
(5)          For the purposes of this Statement of Principles, myeloma, in relation to a person, includes death from a terminal event or condition that was contributed to by the person's myeloma.
            Note: terminal event is defined in the Schedule 1 - Dictionary.
     8               Basis for determining the factors
The Repatriation Medical Authority is of the view that there is sound medical‑scientific evidence that indicates that myeloma and death from myeloma can be related to relevant service rendered by veterans, members of Peacekeeping Forces, or members of the Forces under the VEA, or members under the MRCA.
Note: MRCA, relevant service and VEA are defined in the Schedule 1 - Dictionary.
     9               Factors that must exist
At least one of the following factors must as a minimum exist before it can be said that a reasonable hypothesis has been raised connecting myeloma or death from myeloma with the circumstances of a person's relevant service:
(1)          having received a cumulative equivalent dose of at least 0.1 sievert of ionising radiation to the bone marrow at least five years before the clinical onset of myeloma;
Note: cumulative equivalent dose is defined in the Schedule 1 - Dictionary.
(2)          inhaling, ingesting or having cutaneous contact with a chemical agent contaminated by 2,3,7,8-tetrachlorodibenzo-para-dioxin (TCDD):
(a)          for a cumulative period of at least 1,000 hours, within a consecutive period of 10 years before the